Canaccord Genuity Analysts Give Quest Diagnostics Incorporated (DGX) a $102.00 Price Target

Canaccord Genuity Analysts Give Quest Diagnostics Incorporated (DGX) a $102.00 Price Target


The brokerage presently has a "buy" rating on the stock. Canaccord Genuity's price target would suggest a potential upside of 9.81% from the stock's previous close.



from Biotech News